Fmoc-3,4-dehydroPro-OH

Fmoc-3,4-dehydroPro-OH is an Fmoc-protected dehydroproline carboxylic acid derivative that retains a rigid, conformationally biased cyclic pyrrolidine framework with an unsaturated 3,4-dehydro motif. The molecule contains a terminal carboxylic acid for peptide coupling, an N-Fmoc protecting group for orthogonal base-mediated deprotection, and an alkene within the ring that can influence local backbone geometry and reactivity during peptide assembly. The defined stereochemical relationship at the dehydroproline center(s) makes it a chiral amino acid building block for stereocontrolled peptide synthesis and for generating constrained peptidomimetic scaffolds. The presence of the Fmoc chromophore and the carboxylic acid enables straightforward incorporation into protected amino acid strategies while supporting downstream functionalization of the unsaturation for synthetic diversification.

1. Peptide Synthesis

Fmoc-3,4-dehydroPro-OH is used in peptide synthesis workflows where a dehydroproline residue is required to impose conformational constraints and modulate backbone turn propensity. The Fmoc-protected nitrogen supports standard solid-phase or solution-phase peptide coupling after base-triggered Fmoc removal, while the free carboxylic acid participates in amide bond formation using peptide coupling chemistries compatible with unsaturated amino acid building blocks. The ring alkene can be retained through assembly to generate peptide analogs with altered geometry, or can serve as a handle for subsequent post-assembly derivatization. Dehydroproline incorporation can be applied to generate structurally defined peptide libraries for mechanistic studies and scaffold optimization in amino acid chemistry and peptide science.

2. Peptidomimetics And SAR

Fmoc-3,4-dehydroPro-OH is suitable for peptidomimetic construction in structure-activity relationship studies that require backbone rigidity and altered dihedral preferences compared with saturated proline analogs. The constrained pyrrolidine ring bearing a 3,4-dehydro double bond provides a stereochemically informative element that can be positioned within a peptide sequence to tune molecular recognition and conformational ensembles. The Fmoc protection strategy enables systematic substitution at the amino acid level, supporting SAR-driven synthesis of analog series with controlled stereochemistry at the dehydroproline residue. Downstream, the unsaturation can be leveraged for generating additional analogs through selective transformations, supporting iterative medicinal chemistry research without changing the core peptide coupling logic.

3. Side-Chain Functionalization

Fmoc-3,4-dehydroPro-OH supports side-chain functionalization and unsaturation-based diversification strategies where the internal alkene can be transformed into new functional motifs after peptide assembly or during fragment construction. The dehydroproline double bond can undergo chemoselective additions or oxidative/functional group interconversions under conditions chosen to preserve the peptide-compatible protecting group pattern, while the carboxylic acid functionality enables controlled conjugation or activation to intermediate derivatives. Fmoc protection provides a stable N-protected handle during synthesis, allowing sequential introduction of additional groups while maintaining orthogonality between N-deprotection and later functionalization steps. The resulting functionalized amino acid or peptide analogs can be used to generate chemically distinct probes for biochemical research and to expand the chemical space accessible from a single chiral amino acid intermediate.

4. Chemical Biology Probes

Fmoc-3,4-dehydroPro-OH can be applied in chemical biology research to produce peptide-based probes that incorporate conformationally constrained residues for improved stability and defined presentation of functional groups. The Fmoc-protected amino acid format enables incorporation into labeled or reactive peptide constructs, where the dehydroproline unit can influence local structure around binding interfaces or recognition elements. The carboxylic acid and the unsaturated ring can be used to design peptide conjugates that undergo subsequent derivatization into clickable handles, affinity tags, or reporter-bearing analogs while preserving the peptide backbone architecture. The combination of chiral dehydroproline stereochemistry and peptide coupling compatibility makes the compound a practical intermediate for generating sequence-defined tools used in biochemical investigations.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-3,4-dehydroPro-OH is relevant to pharmaceutical manufacturing and process chemistry contexts that require robust, reproducible protected amino acid inputs for peptide intermediate preparation. The N-Fmoc protecting group provides a well-established deprotection handle, supporting manufacturing-friendly orthogonality between base-mediated Fmoc removal and amide bond formation at the carboxylic acid. The defined dehydroproline structure can be incorporated as a controlled stereochemical unit within peptide intermediates, enabling downstream processing to final peptide drug substance candidates or peptide-based intermediates for further derivatization. The presence of a stable aromatic Fmoc group also supports analytical traceability during manufacturing development, while the carboxylic acid functionality ensures compatibility with standard peptide coupling and purification workflows used for fine chemical synthesis.

6. Analytical Research Standards

Fmoc-3,4-dehydroPro-OH can be employed in analytical research for preparing peptide standards and calibration materials that contain dehydroproline residues with defined stereochemistry. The Fmoc chromophore and the carboxylic acid enable construction of characterized peptide fragments that can serve as reference compounds for LC-MS, HPLC, or method development targeting unsaturated amino acid motifs. The controlled incorporation of the 3,4-dehydro unit supports method validation for detecting conformationally constrained peptide species and for distinguishing isomeric or stereochemical variants in peptide analysis. The compound thus functions as a chemically defined amino acid building block for generating analytical standards and characterization samples used in applied peptide science and amino acid derivative research.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment